Sort
8,912 grants matching “sars cov 2”
RBD recombinant protein-based SARS vaccine for biodefense
$1,165,855Peter J Hotez · Baylor College Of Medicine · R01 · FY2016 · AI
RBD recombinant protein-based SARS vaccine for biodefense
$1,165,726Peter J Hotez · Baylor College Of Medicine · R01 · FY2015 · AI
A Lung-chip microphysiological system to model SARS-CoV-2 infection and test novel therapeutics
$1,163,750Clive Niels Svendsen · Cedars-Sinai Medical Center · UG3 · FY2020 · NS
Evolutionary Analysis and Comparative Genomics of Protein Superfamilies
$1,162,010L Aravind · National Library Of Medicine · ZIA · FY2023 · LM
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach - Phase II
$1,158,954David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2022 · TR
Deciphering the Link between Severe Acute Respiratory Coronavirus 2 Infection and Long-Term Neurological and Pulmonary Sequelae
$1,158,123Xin Sun · University Of California, San Diego · R01 · FY2022 · AT
An Adaptive Intervention Trial of Home Testing with Behavioral Nudges for Improving COVID-19 Testing and Prevention among People Affected by Diabetes
$1,156,661Mary Beth Weber · Emory University · U01 · FY2022 · DK
Immunoengineering
$1,156,567Kaitlyn Sadtler · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2023 · EB
Evaluating the determinants of the spread of COVID-19 between and within rural communities in Mali, West Africa based on blood-fed mosquitoes
$1,155,676Tovi Lehmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Sensory Science and Metabolism; Molecular and Neuronal Mechanisms
$1,155,032Paule Joseph · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology
$1,153,230Nicholas J Mantis · Wadsworth Center · U01 · FY2020 · CA
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
$1,152,360Shuchi Anand · Stanford University · U01 · FY2023 · AI
Casual, Statistical and Mathematical Modeling with Serologic Data
$1,151,877Marc Lipsitch · Harvard School Of Public Health · U01 · FY2023 · CA
The Effects of Oxygen Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$1,151,242Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
$1,143,218Jacek Skarbinski · Kaiser Foundation Research Institute · U01 · FY2020 · CA
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,142,940John Peter Wikswo · Vanderbilt University · UH3 · FY2020 · TR
CIVIC SARS-CoV-2 Research Activities
$1,141,458Tony Moody · Duke University · N01 · FY2021 · AI
ELSA-HCAP 2: Second Administration of the Harmonised Cognitive Assessment Protocol (HCAP) in the English Longitudinal Study of Ageing
$1,140,779Andrew Steptoe · University College London · R01 · FY2022 · AG
Project IMPROVE: Implementing Community-Engaged Intervention Research to Increase Rapid SARS-CoV-2 Self-Testing Among Diverse Underserved and Vulnerable Asian Americans
$1,140,263Grace X Ma · Temple Univ Of The Commonwealth · U01 · FY2023 · MD
HEALthy Brain and Child Development Study at UAB and UA
$1,140,130A. Myriam Peralta-Carcelen · University Of Alabama At Birmingham · U01 · FY2021 · DA
CEIRR: SARS-CoV-2 Research Activities
$1,140,000Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2022 · AI
Identifying COVID-19 vaccine deserts using Machine Learning and Geospatial Analyses to target Community -engaged testing for vulnerable rural populations to prevent localized outbreaks
$1,138,915Brian Hendricks · West Virginia University · U01 · FY2023 · MD
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
$1,137,992Rong Fan · Yale University · U01 · FY2023 · CA
RBD recombinant protein-based SARS vaccine for biodefense
$1,134,359Peter J Hotez · Baylor College Of Medicine · R01 · FY2014 · AI
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
$1,130,292Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2023 · CA